The pathogenesis of psoriasis and the mechanism of action of tazarotene

Journal of the American Academy of Dermatology

Volumn 39, Issue 4 II SUPPL., 1998, Pages

  Duvic, M ^a   Asano, A T ^a   Hager, C ^a   Mays, S ^a   Morhein, ^a   Acklatek, ^a   Carter, ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TAZAROTENE;

CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; GENE INDUCTION; HUMAN; INFLAMMATION; KERATINOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; TOPICAL DRUG ADMINISTRATION;

EID: 0031763758     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(98)70309-3     Document Type: Conference Paper

References (28)

1. T Esgleyes-Ribot RA Chandraratna DA Lew-Kaya Response of psoriasis to a new topical retinoid, AGN 190168 J Am Acad Dermatol 30 1994 581 590
2. WT Schroeder SM Thacher S Stewart-Galetka Type I keratinocyte transglutaminase: expression in human skin and psoriasis J Invest Dermatol 99 1992 27 34
3. A Ishida-Yamamoto H. Iizuka Differences in involucrin immunolabeling within cornified cell envelopes in normal and psoriatic epidermis J Invest Dermatol 104 1995 391 395
4. J Schalkwijk IMJJ van Vlijmen JAC Alkemade GJ de Jongh Immunohistochemical localization of SKALP/elafin in psoriatic epidermis J Invest Dermatol 100 1993 390 393
5. S Nagpal SM Thacher S Patel Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis Cell Growth Differ 7 1996 1783 1791
6. M Thewes R Stadler B Korge D. Mischke Normal psoriatic epidermis expression of hyperproliferation-associated keratins Arch Dermatol Res 283 1991 465 471
7. FM Watt Involucrin and other markers of keratinocyte terminal differentiation J Invest Dermatol 81 1983 100s 103s
8. BA Bernard D Asselineau L Schaffar-Deshayes MY Darmon Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program? J Invest Dermatol 90 1988 801 805
9. HOF Molhuizen HAC Alkemade PLJM Zeeuwen SKALP/elafin: an elastase inhibitor from cultured human keratinocytes J Biol Chem 268 1993 12028 12032
10. M Lackmann P Rajasekariah SE Iismaa Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10 J Immunol 150 1993 2981 2991
11. JT Elder GJ Fisher PB Lindquist Overexpression of transforming growth factor in psoriatic epidermis Science 243 1989 811 814
12. LB Nanney CM Stoscheck M Magid LE King Altered [125I] epidermal growth factor binding and receptor distribution in psoriasis J Invest Dermatol 86 1986 260 265
13. AT Kagramanova LD Tishchenko TT Berezov The ornithine decarboxylase activity of the epidermis in psoriasis as a biochemical index of the hyperproliferative process Bull Eksp Biol Med 115 1993 618 620
14. S Nagpal J Athanikar AS Chandraratna Separation of transactivation and AP1 antagonism functions of retinoic acid receptor J Biol Chem 270 1995 923 927
15. WG Phillips SM Breathnach Psoriasis. Immune indicators and treatment Clin Immunother 1 1994 157 167
16. RM Grossman J Kreuger D Yourish Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes Proc Natl Acad Sci U S A 86 1989 6367 6371
17. BJ Nickoloff GD Karabin JNWN Barker Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis Am J Pathol 138 1991 129 140
18. CEM Griffiths JJ Voorhees BJ Nickoloff Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor J Am Acad Dermatol 20 1989 617 629
19. M Sticherling E Bornscheuer J-M Schröder E. Christophers Localization of neutrophil-activating peptide-1/interleukin-8 immunoreactivity in normal and psoriatic skin J Invest Dermatol 96 1991 26 30
20. JM Schroder H Gregory J Young E. Christophers Neutrophil-activating proteins in psoriasis J Invest Dermatol 98 1992 241 247
21. L Kemeny AS Kenderessy E Olasz Interleukin-8 receptor: a potential target for antipsoriatic therapy Eur J Pharmacol 258 1994 269 272
22. NV Konstantinova D-MT Duong E Remenyik Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts J Invest Dermatol 107 1996 615 621
23. AB Gottlieb B Lifshitz SM Fu Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques J Exp Med 164 1986 1013 1028
24. AT Asano S Nagpal JM Quell Retinoid-responsive gene expression and clinical response to topical tazarotene in psoriasis [poster] Presented at the 54th Annual Meeting of the American Academy of Dermatology; February 10-15, 1996 Washington DC 1996
25. M Duvic S Nagpal AT Asano RAS Chandraratna Molecular mechanisms of tazarotene action in psoriasis J Am Acad Dermatol 37 1997 S18 S24
26. GD Weinstein L Green LA Drake New topical retinoid gel for therapy of psoriasis: dose-ranging study of AGN 190168 J Invest Dermatol 100 1993 332 abst
27. S Nagpal S Patel AT Asano Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin J Invest Dermatol 106 1996 269 274
28. S Nagpal S Patel H Jacobe Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin J Invest Dermatol 109 1997 91 95